Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SSX4 anticorps (AA 69-97)

Cet anticorps Lapin Polyclonal détecte spécifiquement SSX4 dans WB. Il présente une réactivité envers Humain.
N° du produit ABIN5532728

Aperçu rapide pour SSX4 anticorps (AA 69-97) (ABIN5532728)

Antigène

Voir toutes SSX4 Anticorps
SSX4 (Synovial Sarcoma, X Breakpoint 4 (SSX4))

Reactivité

  • 32
  • 1
Humain

Hôte

  • 28
  • 4
Lapin

Clonalité

  • 30
  • 2
Polyclonal

Conjugué

  • 15
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp SSX4 est non-conjugé

Application

  • 24
  • 19
  • 2
  • 2
  • 1
Western Blotting (WB)
  • Épitope

    • 7
    • 6
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 69-97

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This SSX4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 69-97 amino acids from the Central region of human SSX4.

    Isotype

    Ig Fraction
  • Indications d'application

    For WB starting dilution is: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5 mg/mL

    Buffer

    Supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
  • Antigène

    SSX4 (Synovial Sarcoma, X Breakpoint 4 (SSX4))

    Autre désignation

    SSX4

    Sujet

    The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. Chromosome Xp11 contains a segmental duplication resulting in two identical copies of synovial sarcoma, X breakpoint 4, SSX4 and SSX4B, in tail-to-tail orientation. This gene, SSX4B, represents the more centromeric copy. Two transcript variants encoding distinct isoforms have been identified for this gene.

    Poids moléculaire

    22 kDa

    ID gène

    548313, 6759

    UniProt

    O60224
Vous êtes ici:
Chat with us!